---
title: "3 European Dividend Stocks Yielding Up To 5.8%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/282492694.md"
description: "As European markets rally, investors are focusing on dividend stocks for steady income. Notable stocks include Zurich Insurance Group (4.48% yield), Teleperformance (9.08%), and ING Bank Slaski (5.9%). Manitou BF and Medistim also show potential with yields of 3.5% and 3.4%, respectively, though their financial stability varies. Overall, the European dividend stock landscape offers opportunities for income and growth amid easing geopolitical tensions."
datetime: "2026-04-13T06:02:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/282492694.md)
  - [en](https://longbridge.com/en/news/282492694.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/282492694.md)
generator: "portal-rs"
---

# 3 European Dividend Stocks Yielding Up To 5.8%

As European markets experience a rally with the STOXX Europe 600 Index climbing over 3% amid easing geopolitical tensions, investors are increasingly focused on opportunities within dividend stocks. In this environment, selecting stocks that offer robust dividend yields can provide a steady income stream and potential for capital appreciation, making them an attractive option for those looking to balance risk and reward in their portfolios.

### Top 10 Dividend Stocks In Europe

**Name**

**Dividend Yield**

**Dividend Rating**

Zurich Insurance Group (SWX:ZURN)

4.48%

★★★★★★

Teleperformance (ENXTPA:TEP)

9.08%

★★★★★★

Telekom Austria (WBAG:TKA)

4.40%

★★★★★★

Swiss Re (SWX:SREN)

4.71%

★★★★★★

Rubis (ENXTPA:RUI)

5.80%

★★★★★★

HEXPOL (OM:HPOL B)

5.45%

★★★★★★

Hannover Rück (XTRA:HNR1)

4.58%

★★★★★★

DKSH Holding (SWX:DKSH)

4.24%

★★★★★★

Cembra Money Bank (SWX:CMBN)

4.19%

★★★★★★

Afry (OM:AFRY)

4.70%

★★★★★☆

Click here to see the full list of 207 stocks from our Top European Dividend Stocks screener.

We'll examine a selection from our screener results.

## Manitou BF (ENXTPA:MTU)

**Simply Wall St Dividend Rating:** ★★★★☆☆

**Overview:** Manitou BF SA, with a market cap of €820.84 million, develops, manufactures, and distributes equipment and services across various regions including France, Southern Europe, Northern Europe, the Americas, Asia, the Pacific, Africa, and the Middle East.

**Operations:** Manitou BF generates revenue through its Products Division, which accounts for €2.14 billion, and its Services & Solutions (S&S) Division, contributing €420.38 million.

**Dividend Yield:** 3.5%

Manitou BF's dividend payments are well-covered by earnings and cash flows, with payout ratios of 41.9% and 15.3%, respectively, suggesting sustainability despite a volatile dividend history over the past decade. The company's price-to-earnings ratio of 12x indicates good value compared to the French market average. However, recent financial results show declining net income from €121.88 million to €68.42 million in 2025, which could impact future dividend stability and growth potential.

-   Get an in-depth perspective on Manitou BF's performance by reading our dividend report here.
-   Insights from our recent valuation report point to the potential undervaluation of Manitou BF shares in the market.

ENXTPA:MTU Dividend History as at Apr 2026

## Medistim (OB:MEDI)

**Simply Wall St Dividend Rating:** ★★★★☆☆

**Overview:** Medistim ASA is a company that develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery across the United States, Asia, Europe, and internationally with a market cap of NOK4.24 billion.

**Operations:** Medistim ASA generates revenue from two main segments: Medistim Products, contributing NOK598.53 million, and Third-Party Products, which account for NOK101.24 million.

**Dividend Yield:** 3.4%

Medistim ASA's dividend yield of 3.45% is stable and has grown over the past decade, though it falls short of Norway's top dividend payers. The high payout ratio of 91.8% suggests dividends are not well-covered by earnings, but cash flows do support payouts with a 76.3% cash payout ratio. Recent financials show robust growth, with net income rising to NOK 159.21 million in 2025 from NOK 103.83 million the previous year, supporting potential future dividend increases despite coverage challenges.

-   Delve into the full analysis dividend report here for a deeper understanding of Medistim.
-   Our valuation report here indicates Medistim may be overvalued.

OB:MEDI Dividend History as at Apr 2026

## ING Bank Slaski (WSE:ING)

**Simply Wall St Dividend Rating:** ★★★★☆☆

**Overview:** ING Bank Slaski S.A., with a market cap of PLN59.17 billion, offers a range of banking products and services to retail clients and businesses in Poland through its subsidiaries.

**Operations:** ING Bank Slaski S.A. generates revenue through a variety of banking products and services tailored for both individual and corporate clients in Poland.

**Dividend Yield:** 5.9%

ING Bank Slaski's dividend of PLN 26.71 per share reflects a covered payout ratio of 75.1%, with future coverage projected to improve to 56.5%. Despite a volatile dividend history, payments have increased over the past decade. Recent earnings show net income growth from PLN 4.37 billion to PLN 4.63 billion in 2025, supporting current dividends despite high bad loans at 3.3%. However, its yield is lower than Poland's top payers at 5.87%.

-   Click here to discover the nuances of ING Bank Slaski with our detailed analytical dividend report.
-   Our comprehensive valuation report raises the possibility that ING Bank Slaski is priced higher than what may be justified by its financials.

WSE:ING Dividend History as at Apr 2026

## Key Takeaways

-   Take a closer look at our Top European Dividend Stocks list of 207 companies by clicking here.
-   Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
-   Join a community of smart investors by using Simply Wall St. It's free and delivers expert-level analysis on worldwide markets.

## Searching for a Fresh Perspective?

-   Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
-   Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
-   Find companies with promising cash flow potential yet trading below their fair value.

 *This article by Simply Wall St is general in nature. **We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.** It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.*

### **New:** Manage All Your Stock Portfolios in One Place

We've created the **ultimate portfolio companion** for stock investors, **and it's free.**

• Connect an unlimited number of Portfolios and see your total in one currency  
• Be alerted to new Warning Signs or Risks via email or mobile  
• Track the Fair Value of your stocks  

Try a Demo Portfolio for Free

### Related Stocks

- [ZURVY.US](https://longbridge.com/en/quote/ZURVY.US.md)
- [TLPFY.US](https://longbridge.com/en/quote/TLPFY.US.md)

## Related News & Research

- [Orkla Non-GAAP EPS of NOK 1.60, revenue of NOK 16.7B](https://longbridge.com/en/news/296456178.md)
- [Vow ASA GAAP EPS of NOK 0.02, revenue of NOK 252.9M](https://longbridge.com/en/news/296331370.md)
- [Voya Global Equity Dividend and Premium Opportunity Fund declares $0.05 dividend](https://longbridge.com/en/news/296144461.md)
- [Voya Global Advantage and Premium Opportunity Fund declares $0.085 dividend](https://longbridge.com/en/news/296144838.md)
- [Badger Meter raises dividend by 10% to $0.44](https://longbridge.com/en/news/296120783.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**